Literature DB >> 30482463

KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.

P P Banerjee1, L Pang2, S S Soldan3, S M Miah4, A Eisenberg5, S Maru5, A Waldman5, E A Smith6, Y Rosenberg-Hasson7, D Hirschberg7, A Smith6, D V Ablashi8, K S Campbell4, J S Orange6.   

Abstract

Interactions between germline-encoded natural killer (NK) cell receptors and their respective ligands on tumorigenic or virus-infected cells determine NK cell cytotoxic activity and/or cytokine secretion. NK cell cytokine responses can be augmented in and can potentially contribute to multiple sclerosis (MS), an inflammatory disease of the central nervous system focused upon the oligodendrocytes (OLs). To investigate mechanisms by which NK cells may contribute to MS pathogenesis, we developed an in vitro human model of OL-NK cell interaction. We found that activated, but not resting human NK cells form conjugates with, and mediate cytotoxicity against, human oligodendrocytes. NK cells, when in conjugate with OLs, rapidly synthesize and polarize IFN-γ toward the OLs. IFN-γ  is capable of reducing myelin oligodendrocyte and myelin associated glycoproteins (MOG and MAG) content. This activity is independent of MHC class-I mediated inhibition via KIR2DL1, but dependent upon the interaction between NK cell-expressed KIR2DL4 and its oligodendrocyte-expressed ligand, HLA-G. NK cells from patients with MS express higher levels of IFN-γ following conjugation to OLs, more actively promote in vitro reduction of MOG and MAG and have higher frequencies of the KIR2DL4 positive population. These data collectively suggest a mechanism by which NK cells can promote pathogenic effects upon OLs.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Demyelination; Multiple sclerosis; Myelin protein; Natural killer cell; Oligodendrocyte

Mesh:

Substances:

Year:  2018        PMID: 30482463      PMCID: PMC6543535          DOI: 10.1016/j.molimm.2018.09.027

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  89 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.

Authors:  DeRen Huang; Fu-Dong Shi; Steffen Jung; Gary C Pien; Jintang Wang; Thais P Salazar-Mather; Toby T He; Jennifer T Weaver; Hans-Gustaf Ljunggren; Christine A Biron; Dan R Littman; Richard M Ransohoff
Journal:  FASEB J       Date:  2006-05       Impact factor: 5.191

3.  Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells.

Authors:  S Rajagopalan; J Fu; E O Long
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

4.  Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis.

Authors:  J E Martínez-Rodríguez; M López-Botet; E Munteis; J Rio; J Roquer; X Montalban; M Comabella
Journal:  Clin Immunol       Date:  2011-09-21       Impact factor: 3.969

5.  Exacerbations of multiple sclerosis in patients treated with gamma interferon.

Authors:  H S Panitch; R L Hirsch; A S Haley; K P Johnson
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

6.  Active human herpesvirus 6 infection in patients with multiple sclerosis.

Authors:  Roberto Alvarez-Lafuente; Carlos Martín-Estefanía; Virginia de Las Heras; Carmen Castrillo; Juan José Picazo; Eduardo Varela de Seijas; Rafael Arroyo González
Journal:  Arch Neurol       Date:  2002-06

Review 7.  The immunogenetics of neurological disease.

Authors:  Maneesh K Misra; Vincent Damotte; Jill A Hollenbach
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

8.  Infectious agents and different course of multiple sclerosis: a systematic review.

Authors:  Alia Saberi; Shahin Akhondzadeh; Samaneh Kazemi
Journal:  Acta Neurol Belg       Date:  2018-07-13       Impact factor: 2.396

Review 9.  CCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis.

Authors:  Anna Pittaluga
Journal:  Front Immunol       Date:  2017-09-04       Impact factor: 7.561

Review 10.  The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity.

Authors:  Marina Babic; Chiara Romagnani
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

View more
  4 in total

Review 1.  Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Xiaoyin Bu; Jinman Zhong; Weiru Li; Shengchun Cai; Ya Gao; Baohong Ping
Journal:  Ann Hematol       Date:  2021-03-11       Impact factor: 3.673

2.  Key Role of the CD56lowCD16low Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells.

Authors:  Elisabetta Vulpis; Helena Stabile; Alessandra Soriani; Cinzia Fionda; Maria Teresa Petrucci; Elena Mariggio'; Maria Rosaria Ricciardi; Marco Cippitelli; Angela Gismondi; Angela Santoni; Alessandra Zingoni
Journal:  Cancers (Basel)       Date:  2018-11-29       Impact factor: 6.639

Review 3.  NK Cells in Autoimmune Diseases: Protective or Pathogenic?

Authors:  Meifang Liu; Shujuan Liang; Cai Zhang
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

4.  Analysis of whole exome sequencing in severe mental illness hints at selection of brain development and immune related genes.

Authors:  Jayant Mahadevan; Ajai Kumar Pathak; Alekhya Vemula; Ravi Kumar Nadella; Biju Viswanath; Sanjeev Jain; Meera Purushottam; Mayukh Mondal
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.